Paradigm, Strategies In Wealth Management, LLC Sorrento Therapeutics, Inc. Transaction History

Paradigm, Strategies In Wealth Management, LLC

  • $153 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 15, 2021
SELL
$7.41 - $10.99 $11,781 - $17,474
-1,590 Closed
0 $0
Q1 2021

Apr 29, 2021
BUY
$7.03 - $16.51 $11,177 - $26,250
1,590 New
1,590 $13,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Paradigm, Strategies In Wealth Management, LLC Portfolio

Follow Paradigm, Strategies In Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm, Strategies In Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm, Strategies In Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email